We are international
Donate
• treatment options TEXT SIZE   
bone disease    back

ASCO 2010: Response of newly diagnosed myeloma with 1q21 amplification to bortezomib-based PAD induction therapy.
Douglas Joshua, MD
University of Sydney
Sydney, Australia
06.09.10

Be the first to comment

 related articles